Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region

This study has been completed.

Study NCT00197028 Information provided by GlaxoSmithKline

First Received: September 13, 2005 Last Updated: October 1, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2007
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: October 1, 2009